Innovative Medicines Initiative
Company Description
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
To know more, please visit www.imi.europa.eu.
Job of the week
EURACTIV News
- Commissioner Hahn: EU should expand budget, link payments to structural reforms
- Meta faces EU investigation for potential digital rulebook violations and disinformation risks
- The EUDR deadline is approaching – how can companies meet the requirements? [Promoted content]
- European Commission ‘prepared’ in the face of US bird flu outbreak
- European bridges secure against ship collisions, port authorities say
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
Subscribe to our jobletter!